Ariel Precision Medicine
Going Beyond Genetics
Ariel Precision Medicine (Ariel) is a genomic health information technology company that is spearheading a new approach to complex disease care using precision medicine for the diagnosis, monitoring & tailored treatment of complex disease, starting with pancreatitis, pancreatic cancer, gastrointestinal and other complex diseases.
Ariel’s technologies are leading the paradigm shift from single-gene genetics to complex gene-to-gene interactions and the integration of lifestyle and environmental factors to provide a more comprehensive view of disease trajectory and precise therapeutic options.
MCC invested in Ariel Precision Medicine to advance the development of new therapeutics to treat genetically driven recurrent acute pancreatitis, chronic pancreatitis, and other difficult diseases.Our collaboration with Ariel has already advanced research and development in the field bringing us closer than ever to new medicines that will improve the lives of millions of children and adults suffering from pancreatitis and other complex diseases and conditions.